CLSYX
Price
$26.68
Change
-$0.13 (-0.48%)
Updated
Jul 24 closing price
Net Assets
687.57M
HFQRX
Price
$8.10
Change
-$0.05 (-0.61%)
Updated
Jul 23 closing price
Net Assets
7.55B
Interact to see
Advertisement

CLSYX vs HFQRX

CLSYX vs HFQRX Comparison Chart in %
View a ticker or compare two or three
VS
CLSYX vs. HFQRX commentary
Jul 26, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CLSYX is a Hold and HFQRX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
HFQRX has more cash in the bank: 7.55B vs. CLSYX (688M). HFQRX pays higher dividends than CLSYX: HFQRX (6.36) vs CLSYX (2.61). CLSYX was incepted earlier than HFQRX: CLSYX (17 years) vs HFQRX (11 years). CLSYX (0.83) is less costly to investors than HFQRX (0.69). HFQRX is a more actively managed with annual turnover of: 175.00 vs. CLSYX (13.00). CLSYX (1000000) and HFQRX (1000000) have matching initial minimum investment requirements. CLSYX annual gain was more profitable for investors over the last year : 24.78 vs. HFQRX (22.61). HFQRX return over 5 years is better than : 73.83 vs. CLSYX (43.20).
CLSYXHFQRXCLSYX / HFQRX
Total Expense Ratio0.770.69112%
Annual Report Gross Expense Ratio0.830.69120%
Fund Existence17 years11 years-
Gain YTD15.97914.833108%
Front LoadN/AN/A-
Min. Initial Investment10000001000000100%
Min. Initial Investment IRAN/AN/A-
Net Assets688M7.55B9%
Annual Yield % from dividends2.616.3641%
Returns for 1 year24.7822.61110%
Returns for 3 years51.7463.7881%
Returns for 5 years43.2073.8359%
Returns for 10 years88.80130.0768%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
TWEAX9.360.09
+0.97%
American Century Equity Income A
DDVIX12.750.12
+0.95%
Nomura Value Institutional
DFDPX35.270.11
+0.31%
DF Dent Premier Growth Investor
LHCIX23.64-0.04
-0.17%
Lord Abbett Health Care I
SSTFX9.67-0.12
-1.23%
Virtus KAR Capital Growth C